189 related articles for article (PubMed ID: 21251731)
1. Optimization and in vitro toxicity evaluation of G4 PAMAM dendrimer-risperidone complexes.
Prieto MJ; Temprana CF; del Río Zabala NE; Marotta CH; Alonso Sdel V
Eur J Med Chem; 2011 Mar; 46(3):845-50. PubMed ID: 21251731
[TBL] [Abstract][Full Text] [Related]
2. Optimization and in vivo toxicity evaluation of G4.5 PAMAM dendrimer-risperidone complexes.
Prieto MJ; del Rio Zabala NE; Marotta CH; Carreño Gutierrez H; Arévalo Arévalo R; Chiaramoni NS; del Valle Alonso S
PLoS One; 2014; 9(2):e90393. PubMed ID: 24587349
[TBL] [Abstract][Full Text] [Related]
3. Interaction between PAMAM-NH₂ G4 dendrimer and 5-fluorouracil in aqueous solution.
Buczkowski A; Sekowski S; Grala A; Palecz D; Milowska K; Urbaniak P; Gabryelak T; Piekarski H; Palecz B
Int J Pharm; 2011 Apr; 408(1-2):266-70. PubMed ID: 21335079
[TBL] [Abstract][Full Text] [Related]
4. Partially PEGylated PAMAM dendrimers as solubility enhancers of Silybin.
Diaz C; Guzmán J; Jiménez VA; Alderete JB
Pharm Dev Technol; 2018 Sep; 23(7):689-696. PubMed ID: 28368674
[TBL] [Abstract][Full Text] [Related]
5. PEGylated PAMAM dendrimers as a potential drug delivery carrier: in vitro and in vivo comparative evaluation of covalently conjugated drug and noncovalent drug inclusion complex.
Jiang YY; Tang GT; Zhang LH; Kong SY; Zhu SJ; Pei YY
J Drug Target; 2010 Jun; 18(5):389-403. PubMed ID: 20055559
[TBL] [Abstract][Full Text] [Related]
6. Contribution of hydrophobicity, DNA and proteins to the cytotoxicity of cationic PAMAM dendrimers.
Halets I; Shcharbin D; Klajnert B; Bryszewska M
Int J Pharm; 2013 Sep; 454(1):1-3. PubMed ID: 23831196
[TBL] [Abstract][Full Text] [Related]
7. Atomic level insights into realistic molecular models of dendrimer-drug complexes through MD simulations.
Jain V; Maiti PK; Bharatam PV
J Chem Phys; 2016 Sep; 145(12):124902. PubMed ID: 27782646
[TBL] [Abstract][Full Text] [Related]
8. Complexes of dendrimers with bovine serum albumin.
Mandeville JS; Tajmir-Riahi HA
Biomacromolecules; 2010 Feb; 11(2):465-72. PubMed ID: 20085247
[TBL] [Abstract][Full Text] [Related]
9. Dendrimer toxicity: Let's meet the challenge.
Jain K; Kesharwani P; Gupta U; Jain NK
Int J Pharm; 2010 Jul; 394(1-2):122-42. PubMed ID: 20433913
[TBL] [Abstract][Full Text] [Related]
10. Polyamidomine dendrimers: an excellent drug carrier for improving the solubility and bioavailability of puerarin.
Gu L; Wu Zh; Qi X; He H; Ma X; Chou X; Wen X; Zhang M; Jiao F
Pharm Dev Technol; 2013; 18(5):1051-7. PubMed ID: 22303809
[TBL] [Abstract][Full Text] [Related]
11. In vivo efficacy of dendrimer-methylprednisolone conjugate formulation for the treatment of lung inflammation.
Inapagolla R; Guru BR; Kurtoglu YE; Gao X; Lieh-Lai M; Bassett DJ; Kannan RM
Int J Pharm; 2010 Oct; 399(1-2):140-7. PubMed ID: 20667503
[TBL] [Abstract][Full Text] [Related]
12. Studies on polyamidoamine dendrimers as efficient gene delivery vector.
Hui Zhong ; He ZG; Zheng Li ; Li GY; Shen SR; Li XL
J Biomater Appl; 2008 May; 22(6):527-44. PubMed ID: 17623709
[TBL] [Abstract][Full Text] [Related]
13. Binding free energy calculations using MMPB/GBSA approaches for PAMAM-G4-drug complexes at neutral, basic and acid pH conditions.
Martínez-Muñoz A; Bello M; Romero-Castro A; Rodríguez-Fonseca RA; Rodrigues J; Sánchez-Espinosa VA; Correa-Basurto J
J Mol Graph Model; 2017 Sep; 76():330-341. PubMed ID: 28759825
[TBL] [Abstract][Full Text] [Related]
14. Exploring dendrimer towards dual drug delivery: pH responsive simultaneous drug-release kinetics.
Tekade RK; Dutta T; Gajbhiye V; Jain NK
J Microencapsul; 2009 Jun; 26(4):287-96. PubMed ID: 18791906
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of PAMAM dendrimer derivatives with enhanced buffering capacity and remarkable gene transfection efficiency.
Yu GS; Bae YM; Choi H; Kong B; Choi IS; Choi JS
Bioconjug Chem; 2011 Jun; 22(6):1046-55. PubMed ID: 21528924
[TBL] [Abstract][Full Text] [Related]
16. In vivo distribution and toxicity of PAMAM dendrimers in the central nervous system depend on their surface chemistry.
Albertazzi L; Gherardini L; Brondi M; Sulis Sato S; Bifone A; Pizzorusso T; Ratto GM; Bardi G
Mol Pharm; 2013 Jan; 10(1):249-60. PubMed ID: 23163881
[TBL] [Abstract][Full Text] [Related]
17. Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability.
Kolhatkar RB; Kitchens KM; Swaan PW; Ghandehari H
Bioconjug Chem; 2007; 18(6):2054-60. PubMed ID: 17960872
[TBL] [Abstract][Full Text] [Related]
18. In vitro gene delivery using polyamidoamine dendrimers with a trimesyl core.
Zhang XQ; Wang XL; Huang SW; Zhuo RX; Liu ZL; Mao HQ; Leong KW
Biomacromolecules; 2005; 6(1):341-50. PubMed ID: 15638538
[TBL] [Abstract][Full Text] [Related]
19. Probing the binding of cationic lipids with dendrimers.
Mandeville JS; Bourassa P; Tajmir-Riahi HA
Biomacromolecules; 2013 Jan; 14(1):142-52. PubMed ID: 23130659
[TBL] [Abstract][Full Text] [Related]
20. Investigations on the toxicological profile of functionalized fifth-generation poly (propylene imine) dendrimer.
Agashe HB; Dutta T; Garg M; Jain NK
J Pharm Pharmacol; 2006 Nov; 58(11):1491-8. PubMed ID: 17132212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
